The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
Open accessAbstract
Introduction Epithelial circulating tumor cells (CTCs) are detectable in patients with non-small cell lung cancer (NSCLC). However, epithelial to mesenchymal transition, a widely reported prerequisite for metastasis, may lead to an underestimation of CTC number. We compared directly an epithelial marker-dependent (CellSearch) and a marker-independent (isolation by size of epithelial tumor cells [ISET]) technology platform for the ability to identify CTCs. Molecular characteristics of CTCs were also explored.Methods Paired peripheral blood samples were collected from 40 chemonäive, stages IIIA to IV NSCLC patients. CTCs were enumerated by Epithelial Cell Adhesion Molecule-based immunomagnetic capture (CellSearch, Veridex) and by filtration (ISET, RareCell Diagnostics). CTCs isolated by filtration were assessed by immunohistochemistry for epithelial marker expression (cytokeratins, Epithelial Cell Adhesion Molecule, epidermal growth factor receptor) and for proliferation status (Ki67).Results CTCs were detected using ISET in 32 of 40 (80%) patients compared with 9 of 40 (23%) patients using CellSearch. A subpopulation of CTCs isolated by ISET did not express epithelial markers. Circulating tumor microemboli (CTM, clusters of ≥ 3 CTCs) were observed in 43% patients using ISET but were undetectable by CellSearch. Up to 62% of single CTCs were positive for the proliferation marker Ki67, whereas cells within CTM were nonproliferative.Conclusions Both technology platforms detected NSCLC CTCs. ISET detected higher numbers of CTCs including epithelial marker negative tumor cells. ISET also isolated CTM and permitted molecular characterization. Combined with our previous CellSearch data confirming CTC number as an independent prognostic biomarker for NSCLC, we propose that this complementary dual technology approach to CTC analysis allows more complete exploration of CTCs in patients with NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While circulating tumor cells (CTCs) are considered a form of liquid biopsy, and we (31) and others (47) have reported on approaches for molecular analysis of CTCs, NSCLC patient CTCs cannot always be reliably identified (44, 48, 49).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,947
Collective cell migration in morphogenesis, regeneration and cancer
Friedl, P., & Gilmour, D. T. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2720 · Cited by 2,804
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542
Bono, J. S. D., Scher, H. I., Montgomery, B., Parker, C. C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. M. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,189
Cohen, S. J., Punt, C. J. A., Iannotti, N. O., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E. P., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,876
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Stott, S. L., Hsu, C., Tsukrov, D. I., Yu, M., Miyamoto, D. T., Waltman, B. A., Rothenberg, S. M., Shah, A. M., Smas, M. E., Korir, G. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012539107 · Cited by 1,657
Riethdorf, S., Fritsche, H. A., Müller, V., Rau, T., Schindlbeck, C., Rack, B. K., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,365
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.140 · Cited by 1,134
Cited by
Sorted by citations
Items 301–400 of 463
Li, J. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/2680526 · Cited by 11
RetractedCirculating tumor cells in non-small cell lung carcinoma.
Boshuizen, R. C., Kühn, P., & van den Heuvel, M. M. (2012) · PubMed Central · doi:10.3978/j.issn.2072-1439.2012.08.21 · Cited by 12
Yamamoto, S., Fei, J., Okochi, M., Shimizu, K., Yusa, A., Kondo, N., Iwata, H., Nakanishi, H., & Honda, H. (2015) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-015-1412-9 · Cited by 12
Vidic, M., Šmuc, T., Janež, N., Blank, M., Accetto, T., Mavri, J., Nascimento, I. C., Nery, A. A., Ulrich, H., & Lah, T. T. (2018) · Radiology and Oncology · doi:10.2478/raon-2018-0014 · Cited by 12
Mezquita, L., Oulhen, M., Aberlenc, A., Deloger, M., Aldea, M. D., Honoré, A., Lécluse, Y., Howarth, K., Friboulet, L., Besse, B., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-023-02535-0 · Cited by 11
Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments
Talwelkar, S. S., Mäyränpää, M. I., Søraas, L., Potdar, S., Bao, J., Hemmes, A., Linnavirta, N., Lømo, J., Räsänen, J. V., Knuuttila, A., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100373 · Cited by 10
Bocci, F., Mandal, S., Tejaswi, T., & Jolly, M. K. (2021) · Computational and Systems Oncology · doi:10.1002/cso2.1015 · Cited by 11
Hatakeyama, K., Yamakawa, Y., Fukuda, Y., Ohshima, K., Wakabayashi‐Nakao, K., Sakura, N., Tanizawa, Y., Kinugasa, Y., Yamaguchi, K., Terashima, M., et al. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0426-3 · Cited by 11
Jong, E. D., Chan, I. C. W., & Nedelcu, A. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00842 · Cited by 11
Campennì, M., May, A., Boddy, A. M., Harris, V. K., & Nedelcu, A. M. (2020) · Evolutionary Applications · doi:10.1111/eva.12943 · Cited by 11
Tamminga, M., Oomens, L., Hiltermann, T. J. N., Andree, K., Tibbe, A. G. J., Broekmaat, J. J., Schuuring, E. M. D., Terstappen, L. W. M. M., & Groen, H. J. M. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-19-413 · Cited by 11
Silva, V. S. E., Abdallah, E. A., Brito, A. B. C., Braun, A. C., Tariki, M. S., de Mello, C. A. L., Calsavara, V. F., Riechelmann, R. P., & Chinen, L. T. D. (2021) · Diagnostics · doi:10.3390/diagnostics11030502 · Cited by 11
Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration
Wang, L., Duménil, C., Julié, C., Giraud, V., Dumoulin, J., Labrune, S., Chinet, T., Emile, J., He, B., & Leprieur, E. G. (2017) · Oncotarget · doi:10.18632/oncotarget.22651 · Cited by 10
Preliminary data on circulating tumor cells in metastatic NSCLC patients candidate to immunotherapy.
Monterisi, S., Castello, A., Toschi, L., Federico, D., Rossi, S., Veronesi, G., & Lopci, E. (2019) · Europe PMC (PubMed Central) · Cited by 10
Martel, A., Mograbi, B., Roméo, B., Gastaud, L., Lalvée, S., Zahaf, K., Fayada, J., Nahon‐Estève, S., Bonnetaud, C., Salah, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311075 · Cited by 10
Zhang, Y., Yang, Q., Zhu, L., Lu, X., Xin, W., Ding, J., Wang, S., Tang, Z., Fan, G., Cen, Y., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c01122 · Cited by 10
In-vivo isolation of circulating tumor cells in non-small cell lung cancer patients by CellCollector
Gąsiorowski, Ł., Dyszkiewicz, W., & Zielinski, P. (2017) · Neoplasma · doi:10.4149/neo_2017_618 · Cited by 10
Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients
Sánchez‐Herrero, E., Provencio, M., & Romero, A. (2020) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2019-0019 · Cited by 10
Tamminga, M., Groen, H. (. J. M., & Hiltermann, T. J. N. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.04.17 · Cited by 10
Marino, F. Z., Ronchi, A., Accardo, M., & Franco, R. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.38 · Cited by 10
Hsieh, C., & Wu, M. (2016) · InTech eBooks · doi:10.5772/64812 · Cited by 10
Yamamoto, S., Shimizu, K., Fei, J., Iwata, H., Okochi, M., Nakanishi, H., & Honda, H. (2016) · Biotechnology Journal · doi:10.1002/biot.201600084 · Cited by 10
Classifying circulating tumor cells to monitor cancer progression
Economopoulou, P., Georgoulias, V., & Kotsakis, A. P. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1275572 · Cited by 10
Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma
Nicolazzo, C., Colangelo, L., Corsi, A., Carpino, G., Gradilone, A., Sonato, C., Raimondi, C., Gaudio, E., Gazzaniga, P., & Gianni, W. (2018) · Analytical Cellular Pathology · doi:10.1155/2018/9718585 · Cited by 10
Kuvendjiska, J., Pitman, M. B., Martini, V., Braun, C., GREBE, K., Timme, S., Fichtner‐Feigl, S., Glatz, T., Schmoor, C., Guenzle, J., et al. (2020) · Anticancer Research · doi:10.21873/anticanres.14582 · Cited by 10
Xagara, A., Roumeliotou, A., Kokkalis, Α., Tsapakidis, K., Papakonstantinou, D., Papadopoulos, V., Samaras, I., Chantzara, E., Kallergi, G., & Kotsakis, A. P. (2024) · Biomedicines · doi:10.3390/biomedicines12010146 · Cited by 10
Portella, L., Bertolini, G., Guardascione, G., Febbraro, D. G. D., Ieranò, C., D’Alterio, C., Rea, G., Napolitano, M., Santagata, S., Trotta, A. M., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35524 · Cited by 9
Liu, C., Cai, Y., & Mou, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117726 · Cited by 9
Liu, C., Chen, H., Sun, T., Wang, H., Chen, B., & Wang, X. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101052 · Cited by 9
The use of microphysiological systems to model metastatic cancer
Jackson, C. E., Green, N. H., English, W., & Claeyssens, F. (2024) · Biofabrication · doi:10.1088/1758-5090/ad3b70 · Cited by 10
Matikas, A., Voutsina, A., Lagoudaki, E. D., Hatzidaki, D., Trypaki, M., Stoupis, G., Tzardi, M. N., Mavroudis, D., & Georgoulias, V. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.06.005 · Cited by 9
de Oliveira, T. B., Braun, A. C., Nicolau, U. R., Abdallah, E. A., Alves, V. S., de Jesus, V. H. F., Calsavara, V. F., Kowaslki, L. P., & Chinen, L. T. D. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105480 · Cited by 9
Fina, E., Federico, D., Novellis, P., Dieci, E., Monterisi, S., Cioffi, F., Mangiameli, G., Finocchiaro, G., Alloisio, M., & Veronesi, G. (2021) · Cancers · doi:10.3390/cancers13174488 · Cited by 9
Castillo, L. N. G., Méjean, A., Vielh, P. R., Anract, J., Decina, A., Nalpas, B., Benali-Furet, N., Desitter, I., & Paterlini-Bréchot, P. (2022) · Life · doi:10.3390/life12020165 · Cited by 8
Liu, J., Han, M. K., & Huang, H. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.07.10 · Cited by 8
Gao, Y., Cheng, X., & Han, M. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02993-7 · Cited by 8
Circulating Tumor Cells in Desmoid Tumors: New Perspectives
Braun, A. C., Campos, F. A. B., Abdallah, E. A., Ruano, A. P. C., Medina, T. D. S., Tariki, M. S., Pinto, F. F. E., de Mello, C. A. L., & Chinen, L. T. D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.622626 · Cited by 8
Recent advances in lung cancer genomics: Application in targeted therapy
Pathak, N., Chitikela, S. D., & Malik, P. S. (2021) · Advances in genetics · doi:10.1016/bs.adgen.2021.08.004 · Cited by 9
Microfluidics for the Isolation and Detection of Circulating Tumor Cells
Sierra-Agudelo, J., Rodriguez-Trujíllo, R., & Samitier, J. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-04039-9_16 · Cited by 8
Avella, D. M., Manjunath, Y., Singh, A., Deroche, C. B., Kimchi, E. T., Staveley-O’Carroll, K. F., Mitchem, J. B., Kwon, E. O., Li, G., & Kaifi, J. T. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr.2020.04.10 · Cited by 8
[Progress of Liquid Biopsy in Early Diagnosis of Lung Cancer].
Song, Z., & Yang, L. (2018) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2018.08.08 · Cited by 8
Tarazona, J. G. R., Abdallah, E. A., Flores, B. C. T., Braun, A. C., Coutinho‐Camillo, C. M., Marchi, F. A., Ruano, A. P. C., & Chinen, L. T. D. (2021) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-672020210002e1628 · Cited by 7
Bocci, F., Jolly, M. K., & Onuchic, J. N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/563049 · Cited by 7
Jiang, J., Mo, W., Lian, X., Cao, D., Cheng, H., & Wang, H. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12583 · Cited by 6
Acheampong, E., Morici, M., Abed, A., Bowyer, S. E., Asante, D.-B., Lin, W., Millward, M., Gray, E. S., & Beasley, A. B. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04202-y · Cited by 6
Řehulková, A., Chudacek, J., Prokopova, A., Vidlařová, M., Stránská, J., Drábek, J., Potockova, J., Trojanec, R., Vrbková, J., Škarda, J., et al. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-801 · Cited by 5
Update on the role of circulating tumour cells in cancer-associated thrombosis
Castle, J., Blower, E., & Kirwan, C. (2021) · Thrombosis Update · doi:10.1016/j.tru.2021.100066 · Cited by 6
Carvalho, Â., Guimarães‐Teixeira, C., Constâncio, V., FERNANDES, M. R., Macedo‐Silva, C., Henrique, R., Monteiro, F. J., & Jerónimo, C. (2022) · Biomaterials Science · doi:10.1039/d2bm00044j · Cited by 6
Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications
Zhang, X., Barnett, E., Smith, J., Wilkinson, E. J., Subramaniam, R. M., Zarrabi, A. D., Rodger, E. J., & Chatterjee, A. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.06.002 · Cited by 6
Luo, Y., Tseng, P.-C., Lee, Y.-C., Perng, R.-P., Whang‐Peng, J., & Chen, Y.-M. (2016) · Cancer Biomarkers · doi:10.3233/cbm-150537 · Cited by 6
Kozminsky, M., & Nagrath, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803892-5.00019-x · Cited by 6
Sanches, S. M., Braun, A. C., Calsavara, V. F., Barbosa, P. N. V. P., & Chinen, L. T. D. (2021) · Clinics · doi:10.6061/clinics/2021/e2971 · Cited by 6
Tariki, M. S., Barberan, C. C. G., Torres, J. A., Ruano, A. P. C., Costa, D. D. J. F., Braun, A. C., Alves, V. S., Zéqui, S. D. C., da Costa, W. H., Fay, A. P., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154918 · Cited by 5
He, W., Xu, D., Wang, Z., Wu, H., Xiang, X., Tang, B., Jiang, W., Cui, Y., Wang, H., Jiang, N., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1779-5 · Cited by 5
Molecular biomarkers and liquid biopsies in lung cancer
Sankar, K. N., Zeinali, M., Nagrath, S., & Ramnath, N. (2022) · Seminars in Oncology · doi:10.1053/j.seminoncol.2022.06.007 · Cited by 5
Circulating tumor cells as marker of poor prognosis in metastatic lung cancer: a pilot study
Díaz, M., Abdallah, E. A., Tariki, M. S., Braun, A. C., Dettino, A. L. A., Nicolau, U. R., Alves, V. S., & Chinen, L. T. D. (2018) · Applied cancer research/Applied Cancer Research · doi:10.1186/s41241-018-0059-7 · Cited by 5
Beninato, T., Russo, G. L., Leporati, R., Roz, L., & Bertolini, G. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.03.001 · Cited by 4
Nanotechnology-assisted lung cancer diagnosis: biomarkers and imaging
Maskoukian, S., Moradi, A., Shokri, M., Shirangi, A., Bączek, T., Rabiee, N., Saeb, M. R., Farokhi, M., & Mottaghitalab, F. (2025) · Journal of Nanoparticle Research · doi:10.1007/s11051-025-06270-w · Cited by 4
Folate receptor-positive circulating tumor cells in predicting ground-glass nodules malignancy.
Yue, Y.-S., Sun, Z., Cui, Q., & Jiang, G. (2023) · PubMed Central · Cited by 4
Tong, L., & Wan, Y. (2023) · IEEE Access · doi:10.1109/access.2023.3343701 · Cited by 4
Biology and clinical relevance of circulating tumour cells.
Carter, L., Metcalf, R. L., Blackhall, F. H., Dive, C., & Krebs, M. (2012) · PubMed Central · doi:10.3978/j.issn.2072-1439.2012.09.02 · Cited by 4
Self-citationTanrıverdi, Ö., & Öğünç, H. (2015) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155214567160 · Cited by 4
Clinical value of MLH1-negative circulating tumor cells in lung cancer patients
Liang, J., Yang, Q., Zeng, Y., Liu, Y., Liu, Y., Gu, F., Hu, Y., Zhang, K., Zhong, H., & Liu, L. (2019) · Medicine · doi:10.1097/md.0000000000015721 · Cited by 4
Uguen, A. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000931 · Cited by 4
Lung Cancer - Modern Multidisciplinary Management
Park, H. S.-M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92053 · Cited by 4
Ruano, A. P. C., Costa, D. D. J. F., Braun, A. C., Torres, J. A., Pereira, P. H. B., Abdallah, E. A., Barberan, C. C. G., Silva, V. S. E., Bovolim, G., Buim, M. E. C., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154327 · Cited by 4
Qi, C., & Xiong, X. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01022-3 · Cited by 4
Dietrich, N., Castellanos-Martínez, R., Kemmling, J., Heuser, A., Michael Schnoor, A., Schinner, C., & Spindler, V. (2024) · Scientific Reports · doi:10.1038/s41598-024-68493-6 · Cited by 4
Messaritakis, I., Kotsakis, A. P., & Georgoulias, V. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.11.106 · Cited by 4
Circulating Tumour Cells in Lung Cancer
Chemi, F., Mohan, S., & Brady, G. (2019) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-26439-0_6 · Cited by 4
Circulating tumor cells as emerging tumor biomarkers in lung cancer.
Franco, R., Cantile, M., Marino, F. Z., & Pirozzi, G. (2012) · PubMed Central · doi:10.3978/j.issn.2072-1439.2012.08.23 · Cited by 4
Circulating tumor cells are prognostic in SCLC, but still lack clinical application
Tamminga, M., & Groen, H. J. M. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz162 · Cited by 4
Circulating tumor cells in lung cancer
Bordi, P., & Tiseo, M. (2012) · Lung Cancer Management · doi:10.2217/lmt.12.17 · Cited by 3
Ye, X., Yang, X. Z., Carbone, R., Barshack, I., & Katz, R. L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97631 · Cited by 3
Illahi, Y., Siddiqui, N. S., & Nadeem, M. (2020) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2019.11.003 · Cited by 3
RetractedMoving forward with circulating tumor cells and lung cancer.
Hiltermann, T. J. N., van der Wekken, A. J., & Groen, H. J. M. (2012) · PubMed Central · doi:10.3978/j.issn.2072-1439.2012.08.08 · Cited by 3
Molecular Testing in Lung Cancer
Shiau, C. J., & Tsao, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800886-7.00023-6 · Cited by 3
A Noninvasive and Real-Time Method for Circulating Tumor Cell Detection by In Vivo Flow Cytometry
Wei, X., Zhou, J., Zhu, X., Yang, X., Yang, P., & Wang, Q. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7144-2_21 · Cited by 3
Personalized Medicine in Oncology
Vanderwalde, A. M. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-2820-5 · Cited by 4
Circulating tumor cells and beyond
de Wit, S. (2018) · doi:10.3990/1.9789036545662 · Cited by 3
Xu, C., Xu, X., Shao, W., Sun, H., Liu, X., Feng, H., Zuo, X., Gao, J., Wang, G., Yang, X., et al. (2023) · PubMed Central · doi:10.3779/j.issn.1009-3419.2023.106.12 · Cited by 2
Heterogeneity Landscape of Circulating Tumor Cells in Clinical Utility
Alam, M. K., Yanjun, L., Khoo, B. L., Si, T., Zou, H., & Yang, M. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400438 · Cited by 3
Cell surface vimentin-positive circulating tumor cells: developments, and clinical applications
Zhong, J. M., Du, M., Yi, H., Zheng, Y., Yang, M., & Yu, J. (2025) · Medical Oncology · doi:10.1007/s12032-025-03084-7 · Cited by 2
The Use of Circulating Biomarkers in Early Clinical Trials in Patients With Cancer
D’Arcangelo, M., Margetts, J., & Greystoke, A. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.51 · Cited by 2
Required Evidence for Clinical Applications of Liquid Biopsy Using Especially CTCs in Lung Cancer
Tamminga, M., & Groen, H. J. M. (2020) · Applied Sciences · doi:10.3390/app10113704 · Cited by 2
Baek, S., Noh, K., Zhao, Y., Schoemig-Markiefka, B., Ratiu, D., Domröse, C. M., Mallmann, M. R., Mallmann, P., & Pilch, H. (2024) · In Vivo · doi:10.21873/invivo.13791 · Cited by 3
Circulating tumor cells in liquid biopsy: progress and challenges in detection and quantification
Mishra, S., Kumari, S., & Husain, N. (2025) · Academia oncology. · doi:10.20935/acadonco7770 · Cited by 2
Oulhen, M., Pailler, E., Faugeroux, V., & Farace, F. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7144-2_10 · Cited by 2
Molecular Markers in Guiding Lung Cancer Diagnosis and Treatment
Li, V., & Vigneswaran, W. T. (2022) · Journal of Men s Health · doi:10.31083/j.jomh1808164 · Cited by 2
Clinical and Investigational Applications of Liquid Biopsy in Non-Small Cell Lung Cancer
Pérez-Callejo, D., Torrente, M., Romero, A., & Provencio, M. (2016) · Journal of Tumor · doi:10.17554/j.issn.1819-6187.2016.04.95 · Cited by 2
Adams, D. L., & Cristofanilli, M. (2017) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-50956-3_5 · Cited by 2
Corassa, M. P., Guimarães, A. P. G., Sanches, S. M., Fanelli, M. F., Rocha, B. M. M., da Costa, A. A. B. A., Alves, V., Baiocchi, G., & Chinen, L. T. D. (2017) · Applied cancer research/Applied Cancer Research · doi:10.1186/s41241-017-0030-z · Cited by 2
The Implication of Liquid Biopsy in the Non-small Cell Lung Cancer: Potential and Expectation
Ren, J., & Liu, R. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3346-5_10 · Cited by 3
Wakeam, E., Ball, H. G., & Reddy, R. M. (2020) · JTCVS Techniques · doi:10.1016/j.xjtc.2020.07.028 · Cited by 2
Okuda, K., & Nakanishi, R. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.06.003 · Cited by 2
The role and definition of cancer cells in blood
van Dalum, G. (2014) · doi:10.3990/1.9789036538312 · Cited by 2
Çocuk Yoğun Bakım Hastalarında Hiponatreminin Klinik Önemi
Aygün, F., Aras, S., Varol, F., & İrdem, A. K. (2018) · Online Türk Sağlık Bilimleri Dergisi · doi:10.26453/otjhs.434105 · Cited by 1
How could we detect circulating tumor cells in lung cancer patients? A brief study by flow cytometry
Güler, Ö. Ö., Uysal, T., Şi̇mşek, E., & Çarhan, A. (2018) · Online Türk Sağlık Bilimleri Dergisi · doi:10.26453/otjhs.410582 · Cited by 1
Circulating Tumor Microemboli: Characteristics and Clinical Relevance
Abdallah, E. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-69879-9_9 · Cited by 1
Xuan, Y., Gao, Q., Wang, C., & Cai, D. (2024) · PeerJ · doi:10.7717/peerj.17602 · Cited by 1
Metadata
- Authors
- Krebs, M. G., Hou, J.-M., Sloane, R., Lancashire, L., Priest, L., Nonaka, D., Ward, T. H., Backen, A., Clack, G., Hughes, A., Ranson, M., Blackhall, F. H., & Dive, C.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- Cancer Research UK Manchester Institute (GB)
- The Christie NHS Foundation Trust (GB)
- University of Manchester (GB)
- AstraZeneca (United Kingdom) (GB)
- Corresponding author
- Dive, Caroline
- ORCID
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 7
- Issue
- 2
- Pages
- 306-315
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W2037607269
- Cited by
- 463
- References
- 40
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 22 · 2023: 23 · 2022: 29 · 2021: 45 · 2020: 39 · 2019: 38 · 2018: 40 · 2017: 47 · 2016: 51 · 2015: 34 · 2014: 27 · 2013: 31 · 2012: 18
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Thoracic Oncology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- AstraZeneca
- Cancer Research UK (C147/a12328)
- Academy of Medical Sciences (AMS-SGCL7-Krebs)
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Keywords
- circulating tumor cells, non-small cell lung cancer, epithelial-mesenchymal transition, CellSearch, circulating tumor microemboli, epithelial markers, Ki-67 proliferation index, EpCAM, cytokeratin, epidermal growth factor receptor, CTC enumeration, prognostic factors
- MeSH terms
- Adenocarcinoma, Aged, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Cell Separation, Epithelial Cells, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplastic Cells, Circulating, Prognosis, Prospective Studies, Biomarkers, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
